🔗 Share this article

An extensive overhaul of US pediatric immunisation guidelines has resulted in a reduction in the number of routinely recommended vaccines from 17 to 11.

The freshly released list from the Centers for Disease Control and Prevention retains core vaccines for illnesses like poliomyelitis and measles. However, several others, including hepatitis A and B and coronavirus vaccines, are now classified based on personal risk and dependent on "shared medical deliberation" involving doctors and guardians.

"This new guideline is dangerous and needless," stated the AAP, labeling the change.

This sweeping policy change constitutes the most recent major move undertaken under the current administration by Health Secretary Robert F. Kennedy Jr.

Official Justification and International Comparison

Kennedy claimed the overhaul came "following an exhaustive analysis" and "safeguards kids, honors parents, and rebuilds trust in public health."

"This bringing the U.S. pediatric immunization calendar with global standards while enhancing transparency and informed consent," he added.

According to the statement, the new core recommendation for every children will cover vaccines for:

• Measles, mumps, and rubella (MMR)
• Polio
• Pertussis (whooping cough), tetanus, and diphtheria (DTaP/Tdap)
• Haemophilus influenzae type b (Hib)
• Pneumococcal disease
• Human papillomavirus (HPV)
• Varicella (chickenpox)

3 Tiers of Guidance

The revised structure establishes 3 separate tiers of vaccine advice:

1. Universal Vaccines: The eleven immunizations listed above are recommended for all youngsters.
2. Risk-Based Recommendations: This category includes vaccines for RSV, Hep A, Hep B, dengue fever, and meningitis strains (ACWY and B). These are recommended based on a patient's individual risk factors.
3. Shared Decision-Making Group: Vaccinations for the coronavirus, influenza, and a stomach virus are now subject to case-by-case consultation and choice by parents and their doctors.

For the time being, medical insurance will still pay for immunizations that are still recommended until the close of 2025.

International Perspective and Prior Controversy

The CDC conducted a comparison of current childhood recommendations with those of twenty other industrialized nations. It found the US was "a global outlier" in both the quantity of illnesses covered and the number of doses required, the HHS reported.

This latest announcement comes a short time following a different advisory panel adjusted the timing for the first hepatitis B shot. Formerly, a first dose was advised for infants within 24 hours of birth. Revised guidelines last December shifted that to two months after birth if the parent tested non-reactive for hepatitis B.

That prior recommendation was roundly criticised by pediatric doctors, with the AAP calling it "a dangerous step that will hurt kids."